ABBV Insider Trading
AbbVie Inc. | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at AbbVie Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2022-05-11 00:05 | 2022-05-06 | SEVERINO MICHAEL | Officer - Vice Chairman | OPT+S | $151.12 | 300,000 | $45,336,300 | 152,103 | 0.0% |
| 2022-03-26 00:09 | 2022-03-24 | Stewart Jeffrey Ryan | Officer - EVP, Chief Commercial Officer | OPT+S | $159.20 | 27,690 | $4,408,375 | 60,941 | 0.0% |
| 2022-03-12 01:05 | 2022-03-09 | Durkin Brian L | Officer - VP, Controller | OPT+S | $150.01 | 18,628 | $2,794,301 | 19,094 | 0.0% |
| 2022-03-03 01:03 | 2022-03-01 | Gosebruch Henry O | Officer - EVP, Chief Strategy Officer | SELL | $147.29 | 25,000 | $3,682,188 | 16,623 | -60.1% |
| 2022-03-02 02:14 | 2022-03-01 | Gosebruch Henry O | Officer - EVP, Chief Strategy Officer | SELL | $148.26 | 15,000 | $2,223,836 | 41,623 | -26.5% |
| 2022-03-02 02:11 | 2022-03-01 | Sorg Elaine K. | Officer - SVP, US Commercial Operations | SELL | $148.28 | 6,484 | $961,467 | 17,876 | -26.6% |
| 2022-03-02 02:09 | 2022-03-01 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | SELL | $148.26 | 26,432 | $3,918,769 | 13,837 | -65.6% |
| 2022-03-02 02:08 | 2022-03-01 | Stewart Jeffrey Ryan | Officer - EVP, Chief Commercial Officer | SELL | $148.25 | 21,488 | $3,185,598 | 60,941 | -26.1% |
| 2022-03-02 02:07 | 2022-03-01 | Michael Robert A. | Officer - Vice Chairman | SELL | $148.25 | 43,105 | $6,390,247 | 37,877 | -53.2% |
| 2022-02-09 01:13 | 2022-02-07 | Strom Carrie C | Officer - SVP & Pres Global Allerg Aesth | OPT+S | $141.17 | 2,396 | $338,243 | 42,499 | 0.0% |
| 2021-12-22 01:29 | 2021-12-20 | Durkin Brian L | Officer - VP, Controller | OPT+S | $128.51 | 11,790 | $1,515,133 | 16,505 | 0.0% |
| 2021-12-22 01:21 | 2021-12-17 | Schumacher Laura J | Officer - Vice Chairman | OPT+S | $130.24 | 181,670 | $23,660,683 | 213,003 | 0.0% |
| 2021-12-18 01:01 | 2021-12-15 | Stewart Jeffrey Ryan | Officer - EVP, Chief Commercial Officer | SELL | $128.00 | 2,152 | $275,456 | 47,104 | -4.4% |
| 2021-12-15 01:01 | 2021-12-13 | Sorg Elaine K. | Officer - SVP, US Commercial Operations | SELL | $125.85 | 6,458 | $812,739 | 0 | -100.0% |
| 2021-12-11 01:02 | 2021-12-09 | GONZALEZ RICHARD A | Director, Officer - Chairman of the Board and CEO | OPT+S | $123.23 | 174,100 | $21,453,647 | 376,597 | 0.0% |
| 2021-12-09 01:01 | 2021-12-06 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | OPT+S | $120.00 | 50,350 | $6,042,000 | 0 | 0.0% |
| 2021-11-05 00:35 | 2021-11-02 | AUSTIN ROXANNE S | Director | SELL | $116.61 | 71,844 | $8,377,987 | 49,284 | -59.3% |
| 2021-08-26 01:08 | 2021-08-23 | Strom Carrie C | Officer - SVP & Pres Global Allerg Aesth | SELL | $120.00 | 5,057 | $606,840 | 51,047 | -9.0% |
| 2021-08-26 01:08 | 2021-08-23 | Sorg Elaine K. | Officer - SVP, US Commercial Operations | OPT+S | $120.00 | 13,080 | $1,569,600 | 11,595 | 0.0% |
| 2021-05-27 00:20 | 2021-05-24 | SALEKI-GERHARDT AZITA | Officer - EVP, Operations | OPT+S | $116.29 | 86,920 | $10,108,031 | 116,284 | 0.0% |
| 2021-05-05 23:23 | 2021-05-03 | Strom Carrie C | Officer - SVP & Pres Global Allerg Aesth | OPT+S | $112.40 | 4,184 | $470,282 | 59,225 | 0.0% |
| 2021-03-03 04:31 | 2021-03-01 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | SELL | $108.59 | 19,514 | $2,119,041 | 0 | -100.0% |
| 2021-03-03 04:30 | 2021-03-01 | Sorg Elaine K. | Officer - SVP, US Commercial Operations | SELL | $108.61 | 8,440 | $916,642 | 17,595 | -32.4% |
| 2021-03-03 04:26 | 2021-03-01 | Stewart Jeffrey Ryan | Officer - SVP, US Commercial Operations | SELL | $108.59 | 13,773 | $1,495,576 | 50,969 | -21.3% |
| 2021-03-03 04:27 | 2021-03-01 | GONZALEZ RICHARD A | Director, Officer - Chairman of the Board and CEO | OPT+S | $108.61 | 170,113 | $18,476,211 | 376,597 | 0.0% |
| 2021-02-25 02:28 | 2021-02-22 | Sorg Elaine K. | Officer - SVP, US Commercial Operations | OPT+S | $104.72 | 20,195 | $2,114,732 | 32,751 | 0.0% |
| 2020-12-31 21:15 | 2020-12-29 | Stewart Jeffrey Ryan | Officer - EVP, Commercial Operations | OPT+S | $105.00 | 25,290 | $2,655,450 | 50,969 | 0.0% |
| 2020-12-02 01:22 | 2020-11-27 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | OPT+S | $105.00 | 51,990 | $5,458,950 | 0 | 0.0% |
| 2020-11-25 01:34 | 2020-11-20 | Gosebruch Henry O | Officer - EVP, Chief Strategy Officer | SELL | $99.38 | 40,000 | $3,975,048 | 20,006 | -66.7% |
| 2020-11-19 01:04 | 2020-11-16 | ALBAN CARLOS | Officer - Vice Chairman | OPT+S | $100.00 | 115,830 | $11,583,000 | 114,899 | 0.0% |
| 2020-11-13 01:56 | 2020-11-10 | SALEKI-GERHARDT AZITA | Officer - EVP, Operations | SELL | $98.00 | 17,426 | $1,707,748 | 96,441 | -15.3% |
| 2020-11-13 01:55 | 2020-11-04 | SALEKI-GERHARDT AZITA | Officer - EVP, Operations | OPT+S | $93.61 | 4,800 | $449,328 | 113,867 | 0.0% |
| 2020-11-13 01:54 | 2020-11-09 | GONZALEZ RICHARD A | Director, Officer - Chairman of the Board and CEO | OPT+S | $96.88 | 231,604 | $22,437,263 | 318,642 | 0.0% |
| 2020-11-07 00:29 | 2020-11-04 | SEVERINO MICHAEL | Officer - Vice Chairman | SELL | $93.61 | 90,679 | $8,488,461 | 67,281 | -57.4% |
| 2020-11-07 00:29 | 2020-11-04 | SALEKI-GERHARDT AZITA | Officer - EVP, Operations | SELL | $93.61 | 4,800 | $449,328 | 109,067 | -4.2% |
| 2020-07-09 04:19 | 2020-07-07 | ALBAN CARLOS | Officer - Vice Chairman | SELL | $100.00 | 53,325 | $5,332,553 | 114,899 | -31.7% |
| 2020-05-13 00:44 | 2020-05-12 | Stewart Jeffrey Ryan | Officer - SVP, US Commercial Operations | SELL | $90.00 | 23,024 | $2,072,211 | 52,760 | -30.4% |
| 2020-05-08 00:01 | 2020-05-05 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | SELL | $85.00 | 19,445 | $1,652,825 | 0 | -100.0% |
| 2020-04-25 00:07 | 2020-03-20 | Durkin Brian L | Officer - VP, Controller | BUY | $69.00 | 1,550 | $106,950 | 17,644 | +9.6% |
| 2020-03-21 00:34 | 2020-03-18 | Durkin Brian L | Officer - VP, Controller | BUY | $68.20 | 3,750 | $255,755 | 16,844 | +28.6% |
| 2020-03-05 01:14 | 2020-03-03 | RAPP EDWARD J | Director | BUY | $87.87 | 2,875 | $252,617 | 2,875 | +100.0% |
| 2019-10-02 00:52 | 2019-09-27 | RICHMOND TIMOTHY J. | Officer - EVP, Chief HR Officer | SELL | $75.02 | 15,515 | $1,163,873 | 0 | -100.0% |
| 2019-09-18 23:25 | 2019-09-16 | Schumacher Laura J | Officer - Vice Chairman | BUY | $70.42 | 25,000 | $1,760,523 | 164,838 | +17.9% |
| 2019-08-30 23:08 | 2019-08-29 | Donoghoe Nicholas | Officer - SVP, Enterprise Innovation | BUY | $66.19 | 7,525 | $498,057 | 13,090 | +135.2% |
| 2019-08-20 23:16 | 2019-08-16 | Stewart Jeffrey Ryan | Officer - SVP, US Commercial Operations | BUY | $64.44 | 15,552 | $1,002,169 | 65,304 | +31.3% |
| 2019-08-03 00:02 | 2019-07-31 | AUSTIN ROXANNE S | Director | BUY | $65.86 | 55,000 | $3,622,091 | 117,114 | +88.5% |
| 2019-07-31 23:46 | 2019-07-29 | Gosebruch Henry O | Officer - EVP, Chief Strategy Officer | BUY | $67.28 | 30,000 | $2,018,385 | 75,763 | +65.6% |
| 2019-07-31 23:46 | 2019-07-30 | AUSTIN ROXANNE S | Director | BUY | $66.35 | 10,000 | $663,500 | 62,114 | +19.2% |
| 2019-06-28 23:47 | 2019-06-26 | CHASE WILLIAM J | Officer - EVP, Finance & Administration | BUY | $67.30 | 30,400 | $2,045,920 | 169,552 | +21.8% |
| 2019-06-28 23:48 | 2019-06-26 | RAPP EDWARD J | Director | BUY | $67.30 | 7,500 | $504,750 | 30,662 | +32.4% |
How to Interpret $ABBV Trades
Not every insider transaction in AbbVie Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ABBV shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ABBV
Insider activity data for AbbVie Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ABBV, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.